Cargando…

Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study

BACKGROUND: There is no functional pharmacovigilance system in Cambodia to our knowledge. Mobile phone–based tools, such as short message service (SMS) text messages, are increasingly used for surveillance purposes. OBJECTIVE: To pilot-test the FrontlineSMS mobile phone–based tool for notification o...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, Sophie, Goutard, Flavie, Nguon, Kunthy, Tarantola, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications Inc. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636325/
https://www.ncbi.nlm.nih.gov/pubmed/23591700
http://dx.doi.org/10.2196/jmir.2477
_version_ 1782267317621620736
author Baron, Sophie
Goutard, Flavie
Nguon, Kunthy
Tarantola, Arnaud
author_facet Baron, Sophie
Goutard, Flavie
Nguon, Kunthy
Tarantola, Arnaud
author_sort Baron, Sophie
collection PubMed
description BACKGROUND: There is no functional pharmacovigilance system in Cambodia to our knowledge. Mobile phone–based tools, such as short message service (SMS) text messages, are increasingly used for surveillance purposes. OBJECTIVE: To pilot-test the FrontlineSMS mobile phone–based tool for notification of adverse events, using Cambodia’s only International Vaccination Center at the Institut Pasteur du Cambodge as a field site. METHODS: People receiving vaccinations, aged over 18 years, and who owned a cell phone were recruited in the study following informed consent. The names and mobile phone numbers of the participants interviewed were entered each day into the FrontlineSMS software. Two days after being vaccinated, participants received an automatically generated SMS text message asking whether any adverse events had occurred. Their SMS reply was number-coded and exported from the software daily to an Excel spreadsheet and examined before being saved. If the participant replied with a code for a severe adverse event (8 or 9), they were automatically advised to consult the nearest doctor. RESULTS: The active surveillance study was conducted over 72 days in the spring of 2012. Patients agreed to be asked by SMS text message whether unwanted events had occurred after vaccination. Of 1331 persons aged over 18 years referred to the vaccination unit, 184 (13.8%) were asked and agreed to participate. When texted for clinical status 48 hours after vaccination, 52 (28.3%) participants did not reply, 101 (54.9%) sent an immediate SMS reply, and 31 (16.8%) sent an SMS reply after additional prompting. Of the initial 184 participants, 132 (71.7%) replied. These 132 participants received 135 vaccine doses and 109 (82.6%) reported no adverse events, whereas 23 (17.4%) reported adverse events, all benign. CONCLUSIONS: Notification using an SMS-based text message system is already used in Cambodia for syndromic surveillance in health centers and reporting by health care workers. Our results show that such tools can also be useful for notification by patients or health users in Cambodia, especially in an urban setting.
format Online
Article
Text
id pubmed-3636325
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher JMIR Publications Inc.
record_format MEDLINE/PubMed
spelling pubmed-36363252013-04-26 Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study Baron, Sophie Goutard, Flavie Nguon, Kunthy Tarantola, Arnaud J Med Internet Res Original Paper BACKGROUND: There is no functional pharmacovigilance system in Cambodia to our knowledge. Mobile phone–based tools, such as short message service (SMS) text messages, are increasingly used for surveillance purposes. OBJECTIVE: To pilot-test the FrontlineSMS mobile phone–based tool for notification of adverse events, using Cambodia’s only International Vaccination Center at the Institut Pasteur du Cambodge as a field site. METHODS: People receiving vaccinations, aged over 18 years, and who owned a cell phone were recruited in the study following informed consent. The names and mobile phone numbers of the participants interviewed were entered each day into the FrontlineSMS software. Two days after being vaccinated, participants received an automatically generated SMS text message asking whether any adverse events had occurred. Their SMS reply was number-coded and exported from the software daily to an Excel spreadsheet and examined before being saved. If the participant replied with a code for a severe adverse event (8 or 9), they were automatically advised to consult the nearest doctor. RESULTS: The active surveillance study was conducted over 72 days in the spring of 2012. Patients agreed to be asked by SMS text message whether unwanted events had occurred after vaccination. Of 1331 persons aged over 18 years referred to the vaccination unit, 184 (13.8%) were asked and agreed to participate. When texted for clinical status 48 hours after vaccination, 52 (28.3%) participants did not reply, 101 (54.9%) sent an immediate SMS reply, and 31 (16.8%) sent an SMS reply after additional prompting. Of the initial 184 participants, 132 (71.7%) replied. These 132 participants received 135 vaccine doses and 109 (82.6%) reported no adverse events, whereas 23 (17.4%) reported adverse events, all benign. CONCLUSIONS: Notification using an SMS-based text message system is already used in Cambodia for syndromic surveillance in health centers and reporting by health care workers. Our results show that such tools can also be useful for notification by patients or health users in Cambodia, especially in an urban setting. JMIR Publications Inc. 2013-04-16 /pmc/articles/PMC3636325/ /pubmed/23591700 http://dx.doi.org/10.2196/jmir.2477 Text en ©Sophie Baron, Flavie Goutard, Kunthy Nguon, Arnaud Tarantola. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 16.04.2013. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Baron, Sophie
Goutard, Flavie
Nguon, Kunthy
Tarantola, Arnaud
Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study
title Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study
title_full Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study
title_fullStr Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study
title_full_unstemmed Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study
title_short Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study
title_sort use of a text message-based pharmacovigilance tool in cambodia: pilot study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636325/
https://www.ncbi.nlm.nih.gov/pubmed/23591700
http://dx.doi.org/10.2196/jmir.2477
work_keys_str_mv AT baronsophie useofatextmessagebasedpharmacovigilancetoolincambodiapilotstudy
AT goutardflavie useofatextmessagebasedpharmacovigilancetoolincambodiapilotstudy
AT nguonkunthy useofatextmessagebasedpharmacovigilancetoolincambodiapilotstudy
AT tarantolaarnaud useofatextmessagebasedpharmacovigilancetoolincambodiapilotstudy